Anders Härfstrand
Board member
Oncology
Karolinska Institute
Sweden
Biography
Anders Härfstrand Board member since 2017. Born 1956. MD, PhD. Other assignments; Chairman of Härfstrand Consulting, Board member Prothena Plc, Senior Commercial Advisor HBM Partners, Earlier assignments; Chief Executive Officer of BBB Therapeutics BV, President and Chief Executive Officer Europe of Makhteshim Agan Industries Ltd; President and Chief Executive Officer of Humabs BioMed SA; Chief Executive Officer of Nitec Pharma AG, Various executive and management roles at Serono, Pfizer and Pharmacia. Independent of the company, its executive management and in relation to the company’s major shareholders.
Research Interest
Anders Härfstrand Board member since 2017. Born 1956. MD, PhD. Other assignments; Chairman of Härfstrand Consulting, Board member Prothena Plc, Senior Commercial Advisor HBM Partners, Earlier assignments; Chief Executive Officer of BBB Therapeutics BV, President and Chief Executive Officer Europe of Makhteshim Agan Industries Ltd; President and Chief Executive Officer of Humabs BioMed SA; Chief Executive Officer of Nitec Pharma AG, Various executive and management roles at Serono, Pfizer and Pharmacia. Independent of the company, its executive management and in relation to the company’s major shareholders.
